0001622240-14-000002.txt : 20141110 0001622240-14-000002.hdr.sgml : 20141110 20141110152423 ACCESSION NUMBER: 0001622240-14-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141110 DATE AS OF CHANGE: 20141110 EFFECTIVENESS DATE: 20141110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Supreme Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001622240 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-228012 FILM NUMBER: 141208356 BUSINESS ADDRESS: STREET 1: SUITE #430, 580 HORNBY STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3B6 BUSINESS PHONE: 604-674-2191 MAIL ADDRESS: STREET 1: SUITE #430, 580 HORNBY STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3B6 D 1 primary_doc.xml X0707 D LIVE 0001622240 Supreme Pharmaceuticals Inc. SUITE #430, 580 HORNBY STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6C 3B6 604-674-2191 BRITISH COLUMBIA, CANADA None None Corporation true David Stadnyk Suite #430 580 Hornby Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 3B6 Executive Officer Director George Tsafalas Suite #430 580 Hornby Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 3B6 Director Allan Levien Suite #430 580 Hornby Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 3B6 Director Tatiana Kovaleva Suite #430 580 Hornby Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 3B6 Executive Officer Other Health Care Decline to Disclose 06b false 2014-11-05 false true false 0 538049 538049 0 false 12 0 0 0 false Supreme Pharmaceuticals Inc. David Stadnyk David Stadnyk Chair, President and CEO 2014-11-06